Author

Chenyu Zuo

Observed names: C Zuo, Zuo, Chenyu

Institutions: Beijing University of Posts and Telecommunications, Sun Yat-sen University, Shanghai Centennial Scientific (China)

Observed institutions: Beijing University of Posts and Telecommunications, Sun Yat-sen University, Shanghai Centennial Scientific (China)

ORCID: 0009-0000-1902-0712

Observed ORCID: 0009-0000-1902-0712

OpenAlex ID: A5112881313

Cost-effectiveness analysis of budesonide/formoterol SMART therapy versus salmeterol/fluticasone plus as-needed SABA among patients ≥12 years with moderate asthma from the Chinese societal perspective

2024 · Keruo Zhou, Min Zhang, et al. · Journal of Medical Economics · 6

Cost-Effectiveness Analysis of Relmacabtagene Autoleucel for Relapsed or Refractory Large B-Cell Lymphoma in China

2023 · Ziyi Lin, Chenyu Zuo, et al. · Value in Health Regional Issues · 6

Clinical outcomes of radiofrequency catheter ablation guided by intracardiac echocardiography for Chinese atrial fibrillation patients: a single-center, retrospective study

2024 · Dongchen Zhou, Jian Yang, et al. · Journal of Thoracic Disease · 5

Ee150 Cost-effectiveness Analysis of Relmacabtagene Autoleucel Versus Immunochemotherapy in Patients With Relapsed or Refractory Large B-cell Lymphoma (r/r Lbcl) Who Have Failed at Least Two Lines of Systemic Therapy in China

2026 · Keqin Gao, Powei Wu, et al. · Value in Health

High-density mapping guided the modified box and driver ablation for non-paroxysmal atrial fibrillation: a retrospective single-center study

2026 · Weiwu Xiong, Ling Tao, et al. · BMC Cardiovascular Disorders

BA-UNet: A Boundary Augmented Segmentation Network for Cervical Cancer Radiotherapy

2026 · Meijia Wang, Chenyu Zuo, et al. · Journal of Imaging Informatics in Medicine

Radiofrequency ablation using the ThermoCool SmartTouch Catheter guided by ablation index versus antiarrhythmic drugs in atrial fibrillation treatment in China: a cost-consequence analysis.

2024 · Biqi Zhang, Jie Han, et al. · PubMed Central

EE49 Cost-Effectiveness of Relmacabtagene Autoleucel (ANTI-CD19 AUTOLOGOUS CAR-T CELL IMMUNOTHERAPY PRODUCT) Vs Salvage Chemotherapy for Chinese Relapsed or Refractory Large B-Cell Lymphoma Patients

2022 · Z Lin, C Zuo, et al. · Value in Health

Works count: 9

Citation count: 17

H-index: 3

I10-index: